Answers are grounded in this paper and cite their sources.
This study identified for the first time MCID ranges for 6minWT and GMFM-88 in pediatric patients with neurological impairments, offering useful insights for clinicians to evaluate the impact of treatments. Distribution-based methods should be used with caution: methods based on pre-post correlation may underestimate MCID when applied to patients with small improvements over the treatment period. Our results should be complemented with estimates obtained using consensus- and anchor-based approaches.
No takes yet. Share an insight, caveat, or question.
Storm et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: